The vaccine from Pfizer and BioNTech has shown potential in human trials. In a small trial, participants developed higher levels of COVID-19 antibodies than typically seen in infected people. (Reuters)

Sherlock Biosciences has partnered with Binx Health to scale its CRISPR-enabled COVID-19 test. The company plans to make the test available at the point-of-care and in other places like grocery stores, making it the first CRISPR product to come to market. (Forbes)

Submit a cover design for MM&Ms Hall of Femme issue. Design a cover that celebrates the inspirational women who are leading the industry, raising their voices and exerting their influence to make real change happen to enter the contest. The deadline is July 31. (MM&M)

Some government COVID-19 research contracts do not require the drug to be affordable. A report found some contracts allowed companies to bypass laws that ensure taxpayer-funded treatments or vaccines are affordable. (STAT)

Drug companies are suing to block a Minnesota insulin law. The law, which was to go into effect Wednesday, would allow patients to get insulin for $35 and was intended to stop people from rationing the drug because they couldnt afford it. (STAT)

View post:
Five things for pharma marketers to know: Thursday, July 2, 2020 - Roundup - MM&M - Medical Marketing and Media

Comments are closed.